P-A drug identification program
Executive Summary
Association will ask FDA to require marking or imprinting of each OTC drug tablet, capsule, lozenge or oral dose form with identity of medication. In the meantime, P-A has announced a voluntary industry effort. Program will help to promote added consumer awareness and aid in identification of drugs in over-dose cases, P-A says. A similar mandatory program is before the Washington state legislature. P-A is asking the state to defer the plan until a nationwide program is put into effect.